BioSpace News Archive

Novavax, Inc. today announced that it will participate in TD Cowen’s 43rd Annual Health Care Conference.

Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today reported financial results for its fiscal fourth quarter and full year ended December 31, 2022 and recent business highlights.

ORIC Pharmaceuticals, Inc. today announced that management will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, at 2:00 p.m. ET.

Myomo, Inc. today announced that it will report financial results for the three months and year ended December 31, 2022 on March 13, 2023 before the opening of the market.

Marinus Pharmaceuticals, Inc. today announced the grant of inducement awards to 1 new employee.

Aurinia Pharmaceuticals Inc. announced that the Company’s Compensation Committee granted 3 new employees inducement stock options to purchase an aggregate of 89,830 common shares.

The merger of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.

Myomo, Inc. announces that management will presenting at the 35th Annual Roth Conference, March 13-14, 2023 at The Ritz-Carlton, Dana Point, Calif.

Adial Pharmaceuticals, Inc. today provided an update on its regulatory strategy for AD04, the Company’s lead compound for the treatment of Alcohol Use Disorder (AUD).

Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, set up a gene registry web portal and invites people who suffer from treatment-resistant depression (TRD) to visit www.iMatchDepression.com to help identify whether they or someone they know may be eligible to participate in a biomarker-guided global Phase 2b clinical trial (the “ENLIGHTEN” study).